These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 18436110)

  • 1. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of liver lesions: exceptions and atypical lesions.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Preda A; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):95-103. PubMed ID: 18436109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
    Rafaelian O; Coakley FV; Qayyum A; Breiman RS; Yeh BM; Joe BN; Westphalen AC; Feng S
    J Comput Assist Tomogr; 2006; 30(5):796-9. PubMed ID: 16954932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR diagnosis of focal liver lesions].
    Palkó A
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):374-7. PubMed ID: 15049054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
    Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
    Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypervascular hepatic focal lesions: spectrum of imaging features.
    Namasivayam S; Salman K; Mittal PK; Martin D; Small WC
    Curr Probl Diagn Radiol; 2007; 36(3):107-23. PubMed ID: 17484954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
    Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of paediatric liver tumours with pathological correlation.
    Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S
    Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
    Ito K
    Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localisation of focal liver lesions to specific hepatic segments--comparison of multiphase spiral CT and MR imaging.
    Bobek-Billewicz B; Szurowska E; Zapaśnik A; Izycka-Swieszewska E; Gorycki T; Nowakowski M
    Folia Morphol (Warsz); 2002; 61(4):291-7. PubMed ID: 12725499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of hepatocellular carcinoma.
    Onaya H; Itai Y
    Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):757-68. PubMed ID: 11149678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal liver lesions: characterization with quantitative analysis of T2 relaxation time in TSE sequence with double echo time.
    Cittadini G; Santacroce E; Giasotto V; Rescinito G
    Radiol Med; 2004 Mar; 107(3):166-73. PubMed ID: 15031682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of liver lesions.
    Bonder A; Afdhal N
    Clin Liver Dis; 2012 May; 16(2):271-83. PubMed ID: 22541698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
    Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
    Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
    Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
    Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.